R. Erik Holmlin - 03 Jun 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: President and CEO, Director
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol: BNGO
Transactions as of: 03 Jun 2025
Net transactions value: -$277
Form type: 4
Filing time: 03 Jun 2025, 18:58:31 UTC
Previous filing: 18 Mar 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Holmlin R. Erik	President and CEO, Director	C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO	/s/ Jonathan V. Dixon, Attorney-in-Fact	03 Jun 2025	0001579988

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Tax liability	$277	-75	-4.2%	$3.69	1,708	03 Jun 2025	Direct	F1
holding	BNGO	Common Stock						8	03 Jun 2025	Robert Erik Holmlin Traditional IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.